Mindray Medical (MR) Misses Q2 EPS by 1c

Mindray Medical (NYSE: MR) reported Q2 EPS of $0.42, $0.01 worse than the analyst estimate of $0.43. Revenue for the quarter came in at $336.8 million versus the consensus estimate of $360.5 million.

For earnings history and earnings-related data on Mindray Medical (MR) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• SeaStar Medical (ICU) Misses Q1 EPS by 4c
• Gaxos.ai Inc. (GXAI) Reports Q2 EPS of $0.02